GlassScriptPhysician profile
Courtney Helm
NPI 1477098481
$685.02
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $663 · 2022: $22.28.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $124.31 | 2021 | |
| Nestle Healthcare Nutrition INC. | $63.03 | 2021 | |
| Novo Nordisk INC | $62.71 | 2021 | |
| Abbvie INC. | $59.57 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $54.75 | 2021 | |
| Daiichi Sankyo INC. | $47.02 | 2021 | |
| Janssen Pharmaceuticals, INC | $40.55 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.31 | 2021 | |
| Glaxosmithkline, LLC. | $33.03 | 2021 | |
| Pfizer INC. | $31.61 | 2021 | |
| Lilly USA, LLC | $25.27 | 2021 | |
| Boston Scientific Corporation | $22.28 | 2022 | |
| Redhill Biopharma INC. | $21.86 | 2021 | |
| Phadia US INC. | $18.20 | 2021 | |
| Amarin Pharma, INC. | $15.01 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $14.25 | 2021 | |
| Nalu Medical, INC. | $13.26 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Courtney Helm listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.